Keywords: Head & Neck/ENT, Contrast AgentContrast enhancement, a marker of blood-brain barrier breakdown and active inflammation, provides crucial information in brain disease. Quantitative Transient Imaging (QTI) enables robust quantitative T1, T2 and PD mapping. 30 patients with brain tumors, multiple sclerosis and limbic encephalitis underwent a 3T-MRI brain exam which included conventional T1-weighted and QTI sequences acquired before and after contrast media administration. Synthetic T1-weighted images were obtained from the QTI maps. At radiological inspection, all pathological contrast enhancements in conventional images were visible in the synthetic T1-weighted images obtained from postcontrast QTI and showed the same patterns of contrast enhancement.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords